Maria Donniacuo

Via Lecce Monteroni
Lecce, 73047, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Benefits of sacubitril/valsartan alone and in combination with dapagliflozin in a preclinical female model of cardiometabolic and age-related cardiac dysfunction.

Benefits of sacubitril/valsartan alone and in combination with dapagliflozin in a preclinical female model of cardiometabolic and age-related cardiac dysfunction.

Journal: Cardiovascular diabetology
Published: October 22, 2025

Impaired adenosine pathways in HFpEF: insights into cardiorenal alterations and endothelial responses.

Impaired adenosine pathways in HFpEF: insights into cardiorenal alterations and endothelial responses.

Journal: Frontiers in pharmacology
Published: October 07, 2025

Carnosol modulates mPGES-1/PPAR-γ biological axis: from in silico to in vivo clinical imaging and investigations.

Carnosol modulates mPGES-1/PPAR-γ biological axis: from in silico to in vivo clinical imaging and investigations.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 23, 2025

The effects of SGLT2i on cardiac metabolism in patients with HFpEF: Fact or fiction?

The effects of SGLT2i on cardiac metabolism in patients with HFpEF: Fact or fiction?

Journal: Cardiovascular diabetology
Published: December 11, 2024

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects.

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects.

Journal: Frontiers in pharmacology
Published: April 24, 2024

Effects of sacubitril-valsartan on aging-related cardiac dysfunction.

Effects of sacubitril-valsartan on aging-related cardiac dysfunction.

Journal: European journal of pharmacology
Published: March 25, 2024

Editorial Expression of Concern: Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures.

Editorial Expression of Concern: Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures.

Journal: Intensive care medicine
Published: February 14, 2024

Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch.

Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch.

Journal: Cancers
Published: September 28, 2023

Sodium-glucose cotransporter-2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis.

Sodium-glucose cotransporter-2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis.

Journal: Frontiers in pharmacology
Published: June 26, 2023

COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database.

COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database.

Journal: Biomedicines
Published: May 10, 2023

Q-switched Nd:YAG laser protects human keratinocytes from oxidative stress and inflammation via AhR-Nrf2 pathway.

Q-switched Nd:YAG laser protects human keratinocytes from oxidative stress and inflammation via AhR-Nrf2 pathway.

Journal: Lasers in medical science
Published: April 21, 2023

Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias?

Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias?

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 04, 2023
Showing 1-12 of 36

Last Updated: 09/26/2026